Richman et al. [18] studied 69 primary CRC in 68 patients and demonstrated that 10.1% patients displayed intra-tumour heterogeneity in KRAS codons 12, 13 and 2 or BRAF codon 600. The gene discussed is BRAF; the disease is neoplasm.